ÂÜÀòÂÒÂ×

Gregory Botta, MD, Ph.D., is a medical oncologist who specializes in treating solid tumor cancers of the gastrointestinal system, including cancers of the digestive system, esophagus, stomach, gallbladder, pancreas, liver, small intestine, colon, appendix, rectum and anus, and gastrointestinal stromal tumors (GIST).

He has expertise in chemotherapy, immunotherapy, molecular-based therapy, genomic profiling and regenerative approaches to treating malignancies.

An active researcher and associate professor at UC San Diego School of Medicine, he is working on developing new methods for delivering drugs and immunotherapies. He is also interested in regenerating organs damaged by cancer. His research has a special focus on improving outcomes for pancreatic cancer.

Prior to joining UC San Diego Health, Dr. Botta was a cancer researcher at The Scripps Research Institute and Sanford Burnham Prebys Medical Discovery Institute.

Dr. Botta was a postdoctoral scientist at the University of Pennsylvania, Perelman School of Medicine. He completed fellowship training in gastrointestinal oncology at Scripps MD Anderson Cancer Center in San Diego and residency training in internal medicine at Scripps Green in San Diego. He earned his medical degree and a doctorate in molecular and cell biology from Drexel University College of Medicine in Philadelphia.